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Post-translational modifications, including O-GlcNAcylation, play fundamental roles in
modulating cellular events, including transcription, signal transduction, and immune
signaling. Several molecular targets of O-GlcNAcylation associated with pathogen-
induced innate immune responses have been identified; however, the direct regulatory
mechanisms linking O-GlcNAcylation with antiviral RIG-I-like receptor signaling are not
fully understood. In this study, we found that cellular levels of O-GlcNAcylation decline in
response to infection with Sendai virus. We identified a heavilyO-GlcNAcylated serine-rich
region between amino acids 249–257 of the mitochondrial antiviral signaling protein
(MAVS); modification at this site disrupts MAVS aggregation and prevents MAVS-
mediated activation and signaling. O-GlcNAcylation of the serine-rich region of MAVS
also suppresses its interaction with TRAF3; this prevents IRF3 activation and production
of interferon-b. Taken together, these results suggest that O-GlcNAcylation of MAVS may
be a master regulatory event that promotes host defense against RNA viruses.
Keywords: host defense mechanism, innate immunity, mitochondrial antiviral signaling protein, O-linked
N-Acetylglucosamine (O-GlcNAc), RIG-I-like receptors signalingINTRODUCTION
Innate immune signaling in vertebrate species is orchestrated by three types of receptor families;
toll-like-receptors (TLRs), NOD-like receptors, and RIG-I-like receptors (RLRs). Specifically, when
an RNA virus enters a host cell, the viral double-stranded (ds)RNA exposed to the cytoplasm is
detected by RLRs, as opposed to that recognized by TLRs on the cell surface. Upon detection of theorg February 2021 | Volume 11 | Article 5892591
Seo et al. O-GlcNAcylation of MAVS Inhibits Its Activityviral dsRNA, RIG-I undergoes various post-translational
modifications, including acetylation and ubiquitination (1–3).
This activated form of RIG-I then binds to mitochondrial
antiviral signaling protein (MAVS), which is located in the
mitochondrial outer membrane (4). The RIG-I-MAVS
complex induces the formation of fully activated prion-like
aggregates via caspase recruitment domain (CARD-CARD)
interactions (5, 6). The resulting MAVS aggregates then recruit
the E3 ligases, TRAF2, 3, and 6, to promote K63-linked
ubiquitination to activate downstream kinases, including TBK1
and IKKϵ (3, 7). Interferon (IFN) regulatory factor-3 (IRF3) and
NF-kB are then phosphorylated sequentially and translocated to
the nucleus; these transcription factors (TFs) promote the
production of type I IFNs, pro-inflammatory cytokines, and
antiviral factors that are secreted and can modulate the
responses of neighboring cells (5). This process ultimately
contributes to host defense by promoting virus clearance.
Immune cells have well-established TLR systems that facilitate
rapid and precise responses to pathogens. Macrophages play a
significant role in governing optimal interactions between the
TLRs and RLR. By contrast, expression of TLR genes in both
epithelial cells and fibroblasts is remarkably low (8). As such,
MAVS-mediated RLR signaling is a critical component of the
immunological response to RNA virus infection of epithelial cells.
Macrophages rely on important connections between glucose
metabolism and antiviral host responses (9, 10). Specifically,
increased glucose metabolism in macrophages at relatively early
time points after virus infection can accelerate of the development
of the innate immune response (9, 10). However, the relationship
between glucose metabolism and RLR signaling in epithelial cells
at later time point in infection, notably in cells that with ubiquitous
expression of MAVS, should be further evaluated.
The processes leading to O-linked N-Acetylglucosamine (O-
GlcNAc) are regulated by various cellular signals and external
stress stimuli and is among the most sensitive and dynamic of the
post-translational modifications (11, 12). Many proteins in the
nucleus, cytoplasm, and mitochondria are targets of O-GlcNAc
transferase (OGT) (13). OGT catalyzes the reversible attachment of
a GlcNAc moiety to the hydroxyl groups of the serine or threonine
residues using UDP-GlcNAc from the hexosamine biosynthetic
pathway (HBP) as a substrate; O-GlcNAcase (OGA) catalyzes the
removal of O-GlcNAc from the protein target (11–14). O-GlcNAc
modifications serve to modulate mitochondrial motility through
factors including Milton 1 (15) and mitochondrial trafficking via
the actions of trafficking kinesin (TRAK) protein (16); likewise,
O-GlcNAc modifications of proteins including Drp1 and OPA1
serve to regulate mitochondrial fission and fusion (17).
O-GlcNAcylation has been identified at the C-terminus of
MAVS, which is a key adapter protein in the RLR signaling
pathway (9, 10); this modification has been shown to promote
antiviral immunity. Interestingly, the serine/threonine content of
MAVS is ~20% (i.e.,108 of 540 amino acids); as such, many sites
are candidates for post-translational modification besides those
previously identified.
Pathogen infection threatens host cell survival. Results from
several reports have suggested a link between pathogen infectionFrontiers in Immunology | www.frontiersin.org 2and levels of intracellular O-GlcNAcylation. For example, the
DNA viruses herpes simplex virus (HSV) and the
cytomegalovirus rely on OGT activity and O-GlcNAcylation to
support their replication, proliferation, and propagation (18).
Furthermore, high levels of OGT activity and O-GlcNAcylation
were detected in human papillomavirus (HPV)-induced cervical
neoplasms; increased levels of O-GlcNAcylation were observed
in mouse embryonic fibroblasts in response to HPV E6
oncoprotein overexpression (19). Despite these findings, the
way in which host cells defend themselves from virus infection
and promote innate immune signaling via O-GlcNAcylation is
still unclear.
Here, we report that transcription of OGT is dramatically
decreased at early time points after infection with an RNA virus;
this contributes to the depletion of theO-GlcNAcylation ofMAVS
at later time points after infection, which serves to promote an
innate immune response. We also identified a heavily O-
GlcNAcylated serine-rich region of MAVS that spans amino
acids Serine 249 through Serine 257. O-GlcNAcylation was
blocked via deletion of the MAVS serine-rich region (amino
acids 249–257); this promoted the aggregation of MAVS,
strengthened the interaction between MAVS and TRAF3, and
ultimately resulted in an increase in the production of interferon-b
(IFN-b). Collectively, these results provide new insights into the
cross-talk between host defense mechanisms and O-GlcNAc
metabolism and reveal both novel and distinctive antiviral
functions mediated by O-GlcNAcylation.MATERIALS AND METHODS
Cell Cultures
All epithelial cell lines used in this study were incubated at 37°C
in 5% CO2. HEK293 and MDA-MB-231 cells were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM, Lonza, Basel,
Switzerland) supplemented with 10% fetal bovine serum
(HyClone, Logan, UT, USA). A549 was cultured in ATCC-
formulated F-12K Medium (ATCC, USA, Catalog No. 30-
2004) supplemented with 10% fetal bovine serum. HT-29, and
U937 were cultured in Roswell Park Memorial Institute (RPMI)
1640 medium with HEPES and L-glutamine (HyClone, South
Logan, Utah, USA, SH30255.01).
Sendai Virus Infection
SeV (Cantell strain; Charles River Laboratories) was used to
infect cells at a concentration of 100 hemagglutination units
(HAU)/ml. HEK293, A549, and other cells were plated 24 h
before infection. Cells were infected with SeV in serum-free
DMEM or RPMI-1640 for 1 h at 37°C, washed with 1×
phosphate-buffered saline, and incubated in complete medium
for various periods of time as indicated for each experiment.
Plasmids and Transfection
The plasmid pCS4-Myc-MAVS was kindly provided by Dr. Yukiko
Gotoh (University of Tokyo, Tokyo, Japan). Myc-MAVS-1-265 and
Myc-MAVS-266-540 were cloned into the pcDNA3.1-MycHisCFebruary 2021 | Volume 11 | Article 589259
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wild type were prepared by PCR and cloned into the pRK5-Flag
expression vector (Genentech). The mutations were confirmed by
DNA sequence analysis (Bionics, South Korea). The plasmid
pEFBos-Flag-N-RIG was kindly provided by Dr. Michael Gale
(University of Washington School of Medicine, Washington,
USA), and the plasmid pKH3-3XHA-TRAF3 was kindly provided
by Dr. Ying Zhu (Wuhan University, Wuhan, China). Human Flag-
OGT, Flag-OGA, and Myc-OGT were cloned into the p3XFlag-
CMV™-7.1 expression vector (Sigma-Aldrich) and into the
pcDNA3.1-MycHisC vector. For transient overexpression, cells
were transfected using Omicsfect (OmicsBio, Taipei, Taiwan) in
serum-free medium according to the manufacturer’s instructions
for 24–48 h. In this paper, we transfected cells with DNA expression
vectors or with the empty vector as control.
Reagent and RNAi Interference
Cells were treated with 1 mM Thiamet-G (Sigma-Aldrich) for 2
to 4 h before SeV infection or transfections. Cycloheximide
(Sigma-Aldrich) treatment was performed for the times
indicated. Cells were collected at each time point indicated.
Transfection with poly (I:C) (Sigma-Aldrich) was performed
using the TransIT-2020 Transfection Reagent (Mirus Bio,
USA) according to the manufacturer’s instructions. To
establish knock-down of OGT or MAVS via siRNA
interference, cells were transfected with siRNAs targeting OGT
or MAVS with Lipofectamine RNAi MAX (Invitrogen, USA)
according to the manufacturer’s transfection protocol. The
siRNA sequences targeting these proteins were as follows:
siCTL (control), #1, duplex, Cat.SN-1002, Bioneer, Korea
siOGT, #1, sense, 5′- UAAUCAUUUCAAUAACUGCUU
CUGC (dTdT) - 3′ siOGT, #1, antisense, 5′- GCAGAAGC
AGUUAUUGAAAUGAUUA (dTdT) - 3′ siMAVS, #1, sense,
5′- GAGUCAGCCAUGAUUGCUU (dTdT) - 3′ siMAVS, #1,
antisense, 5′- AAGCAAUCAUGGCUGACUC (dTdT) - 3′
siMAVS, #2, sense, 5′- GCUCACCAAUCCAGCACCA (dTdT)
- 3′ siMAVS, #2, antisense, 5′- UGGUGCUGGAUUGGUGAGC
(dTdT) - 3′.
Western Blotting, Succinylated-Wheat
Germ Agglutinin Lectin Precipitation,
and IP
For Western blotting assays, cells were lysed with buffer A
(150 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl (pH7.4), 1%
NP-40) supplemented with a protease inhibitor cocktail (Roche,
Mannheim, Germany) and a phosphatase inhibitor cocktail
(Roche, Germany). Preparation of sWGA was as previously
described (20). Briefly, 1.5 to 2 mg of total cell lysates were
incubated with agarose-conjugated sWGA (Vector Laboratories,
Burlingame, CA, USA) overnight at 4°C. For IP, 1.5 to 2 mg of
total cell lysates were incubated with agarose-conjugated anti-
FLAG antibody (MBL, Woburn, USA) or anti-Myc antibody
(MBL, Woburn, USA) for 2 h at 4°C. For IP of endogenous
MAVS, 3 mg of total cell lysates were incubated with anti-MAVS
antibody (#166583, Santa Cruz, Dallas, TX, USA) overnight at
4°C followed by agarose-conjugated protein A/G (Santa Cruz,Frontiers in Immunology | www.frontiersin.org 3Dallas, TX, USA) for 2 h at room temperature. Purified proteins
in sWGA/IP precipitates were washed four times with buffer B
(150 mM NaCl, 2 mM EGTA, 2 mMMgCl2, 20 mMHEPES (pH
7.4), and 0.1% NP-40) and were eluted with sodium-dodecyl
sulfate (SDS) loading buffer at 95°C for 5 min. The eluents were
analyzed via Western blots probed with specific antibodies
described in the section to follow. For co-IP experiments, 1.5
to 2 mg of total cell lysates were lysed with buffer C (150 mM
NaCl, 0.1 mM EDTA, 1 mM dithiothreitol, 50 mM Tris-HCl (pH
7.4), and 0.5% Triton-X100). For Western blotting, 20 to 30 mg of
total cell lysate was loaded onto 8% to 10% SDS-PAGE gel.
Exceptionally, 60 mg of total cell lysate was loaded on the SDS-
PAGE gel to detect p-IRF3. The same amount of protein was
loaded in each experiment. After separation onto SDS-PAGE gel,
proteins are transferred to NC membrane to detect signals. EZ-
Western kit (DoGenBio) or SuperSignal West Femto
Chemiluminescent Substrate (Thermo Fisher Scientific, Inc.)
and Amersham Imager 600 (GE Healthcare Life Sciences, Little
Chalfont, UK) were used to signal detection. For quantifying
signals, the immunoreactive protein band was detected and the
integrated signal intensity was measured using AI600 imager
system software. Thereafter, O-GlcNAcylation levels were
normalized to integrated signal intensity of b-actin or
GAPDH, the loading control of the same gel for each cell type.
OGT protein levels were normalized to b-actin, a loading control
of the same gel. To quantify proteins and O-GlcNAcylation
levels, Loading control proteins including b-Actin and
GAPDH, and target proteins to observe or O-GlcNAc levels
were measured using AI600 imager system (GE Healthcare,
Chicago, IL, USA) software.
Antibodies
The primary antibodies used for Western blotting included anti-
O-GlcNAc (#MA1-072, Thermo Scientific), anti-OGT (DM17,
#O6264, Sigma-Aldrich), anti-OGA (EPR7154(B) #ab124807,
Abcam), anti-MAVS (#A300-782A, Bethyl Laboratories), anti-
c-Myc (#sc-789, Santa Cruz), anti-GAPDH (#sc-32233, Santa
Cruz), anti-IRF3 (#sc-8092, Santa Cruz), anti-SeV (#PD029,
MBL), anti-FLAG (#PM020, MBL), anti-b-actin (#4970, CST),
and anti-p-IRF3 (D601M, #29047, CST). NC membranes were
probed with primary antibodies followed by secondary
antibodies conjugated with HRP(horseradish peroxidase) in a
ratio of 1:10000. Secondary antibodies included goat anti-rabbit
IgG (#111-035-003, Jackson Immunoresearch), goat anti-mouse
IgG (#115-035-003, Jackson Immunoresearch), and goat anti-
mouse IgM (#115-005-020, Jackson Immunoresearch).
Semi-Denaturing Detergent-
Polyacrylamide Gel Electrophoresis,
Isolation of Mitochondria, and Semi-
Denaturing Detergent-Agarose
Gel Electrophoresis
SDD-PAGE was performed as previously described (21) to detect
SDS-resistant high-molecular weight MAVS aggregates. Briefly,
HEK293 cells were transfected with plasmids encoding Flag-
MAVS or Myc-OGA or empty vector alone; after 24 h, cells wereFebruary 2021 | Volume 11 | Article 589259
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4× sample buffer both with and without b-mercaptoethanol
followed by SDD-PAGE. To detect endogenous MAVS
aggregates, mitochondria were isolated from cultured cells
using a Mitochondria Isolation Kit (#89874, Thermo Scientific,
Rockford, IL, USA) according to the manufacturer’s instructions.
Then, the mitochondrial fraction was re-suspended in 1%
diaminodiphenylmethane-containing lysis buffer and analyzed
by 2% agarose SDD-AGE.
Real-Time Quantitative RT-PCR
Total RNA was extracted from cultured cells using the TRIzol
reagent (Invitrogen, USA). To obtain cDNA, RT was performed
on 1 mg of the extracted total RNA using ReverTra Ace qPCR RT
Master Mix (Toyobo, Japan) according to the manufacturer’s
instructions. The qPCR was conducted using SYBR Premix Ex
Taq (Takara, Japan) using a CFX96™ real-time system (Bio-
Rad). Relative mRNA levels of OGT and IFN-b were normalized
to those of actin. The qPCR primer sequences were as follows:
IFN-b, Forward 5′-AAA CTC ATG AGC AGT CTG CA-3′
IFN-b, Reverse 5′-AGG AGA TCT TCA GTT TCG GAG G-3′
OGT, Forward 5′-CTTTAGCACTCTGGCAATTAAACAG-3′
OGT, Reverse 5′-TCA AAT AAC ATG CCT TGG CTT C-3′
Actin, Forward 5′-AGA GCT ACG AGC TGC CTG AC-3′
Actin, Reverse 5′-AGC ACT GTG TTG GCG TAC AG-3′
Mapping O-GlcNAc Sites in Mitochondrial
Antiviral Signaling Protein
The extracted peptides were dissolved in Solvent A (0.1% formic
acid in H2O). Peptides were separated using a PepMap™ RSLC
C18 column (Thermo Fisher Scientific, San Jose, CA) with a
linear gradient of 2% to 38% Solvent B (0.1% formic acid in
acetonitrile) over 75 min at a flow rate of 300 ml/min. The
sample was analyzed by Orbitrap Fusion Lumos Tribrid mass
spectrometer (Thermo Fisher Scientific, San Jose, CA) that
interfaced with an Easy nanoLC 1200 system (Thermo Fisher
Scientific, San Jose, CA). The spray voltage was set to 1.9 kV and
the temperature of the heated capillary was set to 275°C. The
equipment was set in data-dependent mode with one survey MS
scan followed by 10 MS/MS scans and a dynamic exclusion time
of 30 s. Full scans were acquired at 350 to 1600 m/z. The
resolution on mass spectrometry was 120,000 and the
automatic gain control (AGC) target was set to 4e5. The MS/
MS scans had a resolution of 30,000; the AGC target was set to
5e4 for high-energy collisional dissociation fragmentation. If
oxonium product ions (m/z 204.0867, 138.0545) were observed
in the higher-energy collisional dissociation (HCD) spectra,
EThcD with user-defined charge dependent reaction time
(45.20 ms for 3+ charged, 25.42 ms for 4+ charged) with 15%
or 17% HCD supplemental activation was performed in a
subsequent scan on the same precursor ion selected for HCD.
The EThcD MS/MS scans had a resolution of 30,000 with the
AGC target set to 1e5. The maximum injection time was 120 ms.
Collected MS/MS data were used in a search of the decoy
UniProt human database (Release 2019_11, 186 532 entries) for
the estimation of the false discovery rate (FDR) with the SequestFrontiers in Immunology | www.frontiersin.org 4HT software in Proteome Discoverer 2.2 (Thermo Fisher
Scientific). Precursor and fragment ion tolerance were set to
10 ppm and 0.02 Da, respectively. Trypsin was chosen as the
enzyme with a maximum allowance of up to two missed
cleavages. The following modifications were defined as static
modification of carbamidomethyl (Cys), dynamic modification
of HexNAc 203.079 Da (Ser and Thr), Phospho 79.966 Da (Ser
and Thr), and Oxidation (Met). The data were also searched
against the decoy database and the results were used to calculate
q values of peptide–spectrum matches (PSMs) using the Fixed
Value PSM Validator within the Proteome Discoverer. Peptide
and protein results were filtered to a 1% FDR.
Statistical Analysis
Data are presented as mean ± SEM based on at least three
independent experiments. Statistical analysis was performed
using two-tailed Student t-tests to compare results from two
groups and by One-way analysis of variance for multiple groups.
A P values of <0.05 considered as significant.RESULTS
Reduced O-GlcNAcylation in Response to
Sendai Virus Infection Stimulates the
Innate Immune Response
The glucose concentration in cells is closely associated with the
production of UDP-GlcNAc via the HBP. Lactate, a glucose
intermediate, was recently identified as a suppressor of MAVS-
mediated RLR signaling (22). OGT, an enzyme that promotes O-
GlcNAc cycling and that uses UDP-GlcNAc as a substrate, is
expressed in most tissues, including epithelial cells (23). O-
GlcNAcylation in cells functions as both a nutrient and stress
sensor (12). In this study, we evaluated changes in O-
GlcNAcylation in various types of cells over time in response
to infection with SeV; this is a single-stranded RNA virus
pathogen that presents dsRNA intermediates to pattern
recognition receptors in the cytosol. Global levels of O-
GlcNAcylation were drastically reduced at the later time points
in response to SeV infection of HEK293 and A549 cells (Figure
1A). The primary cell, MEF (mouse embryonic fibroblast) cells,
also showed a decrease in O-GlcNAcylation (Figure 1A).
Furthermore, we also confirmed that SeV infection resulted in
elevated levels of intracellular O-GlcNAcylation in monocyte-
macrophage U937 cells in response to differentiation with
phorbol 12-myristate 13-acetate; these findings are consistent
with those reported previously in which infection of
macrophages with an RNA virus resulted in a substantial
increase in intracellular O-GlcNAcylation (Figure 1A) (9, 10).
As shown in the present study, elevated levels of O-
GlcNAcylation levels were detected only in U937 cells
differentiated into macrophages (Figure S1A); by contrast, the
global decline in O-GlcNAcylation levels was observed in both
undifferentiated and differentiated U937 cells at the later time
points after infection (Figures 1A, S1A). Furthermore, cells of
the breast epithelial line MDA-MB-231 and the colon epithelialFebruary 2021 | Volume 11 | Article 589259
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of O-GlcNAcylation (Figure S1A). In order to confirm that
reduced O-GlcNAcylation levels in the results presented above
are due to host immune responses rather than direct effects of
Sendai virus itself, we treated HEK293 and A549 with poly(I:C)
and then observed the O-GlcNAcylation levels at later points;
however there was no change (Figure S1B). Therefore, we
hypothesized that a global decrease in cel lular O-
GlcNAcylation during the later phases of SeV infection is a
phenomenon common to many cell targets. Remarkably, we also
confirmed that IFN-b expression reached its peak in both
HEK293 and A549 cells at 24 h of SeV infection (Figure 1B).
In addition, MEF cells showed the highest IFN-b expression at 24
h, which is consistent with the expression in HEK293 and A549Frontiers in Immunology | www.frontiersin.org 5(Figure 1B). IFN-b is a major type I interferon that is
synthesized and secreted in response to infection that
promotes viral clearance and host immunity. Therefore, we
speculated that the decrease in cellular O-GlcNAcylation
observed at 24 h of infection may have a direct impact on
IFN-b expression. To examine this hypothesis, we measured
IFN-bmRNA levels in SeV-infected HEK293 and A549 cells that
were treated with the OGA inhibitor, Thiamet-G, using real-time
reverse transcription–polymerase chain reaction (RT-PCR). The
results revealed that transcription of IFN-b was inhibited in
response to increased levels of cellular O-GlcNAcylation
achieved by treatment with Thiamet-G (Figure 1C). We
conversely inhibited OGT activity through siRNA to




FIGURE 1 | Reduced O-GlcNAcylation in response to RNA virus infection activates the innate immune response. (A) O-GlcNAcylation over time after infection with
Sendai virus (SeV; 100 HAU at t = 0) in HEK293, A549, MEF, and PMA-differentiated U937 cells as detected via Western blot analysis. In the graphs, cellular O-
GlcNAcylation was normalized to GAPDH. (B) Expression of IFN-b mRNA over time as measured by real-time qRT-PCR after infection of HEK293 (left), A549
(middle) and MEF (right) cells with SeV (100 HAU). (C) HEK293 (left) and A549 (right) cells were treated with 1 mM of Thiamet-G(+) or PBS (–) for 4 h before infection
with SeV (100 HAU). Cells were collected at 4 and 24 h post-infection. Expression of IFN-b was measured by real-time qPCR. Statistical significance was determined
by two-tailed student t-test. (D) HEK293 cells were transiently transfected with siCTL or siOGT for 48 h before infection with SeV (100 HAU). Cells were collected at
4 and 24 h post-infection. Expression of IFN-b was measured by real-time qPCR. (E, F) Under the same conditions as in (C), phosphorylation of IRF3 (Ser-396-p-
IRF3) was evaluated via Western blot. Replication of SeV in HEK293 (left) and A549 (right) was also evaluated via Western blot. Statistical significance was
determined by two-tailed student t-test. All experiments were repeated at least three times. Each figure was statistically analyzed with the indicated n number.
(A) HEK293 (left, n = 4) A549 (middle to left, n = 3) MEF (middle to right, n = 3) U937(right, n = 4) (B) HEK293 (left, n = 3) A549 (middle, n = 4) MEF (right, n = 3)
(C) HEK293(left, n = 5) A549(middle, n = 3) (D) HEK293(n = 4) (E) HEK293(n = 3) (F) A549(n = 3). Data are presented as mean ± standard error (SEM); *p < 0.05,
**p < 0.01.February 2021 | Volume 11 | Article 589259
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of IFN-b increased in HEK293 when OGT was knocked down
(Figure 1D). Under the same conditions as in Figure 1C,
Thiamet-G introduced 24 h after SeV infection of HEK293 and
A549 cells resulted in reduced phosphorylation of IRF3 by ~19%
and ~17%, respectively, in association with amplified replication
of SeV (Figures 1E, F). These results suggest that reduced levels
of O-GlcNAcylation observed during the later stages of infection
with an RNA virus serves to promote the innate
immune response.
Host Cell-Mediated Downregulation of
O-GlcNAc Transferase Transcription in
Response to Sendai Virus Infection
Cellular levels of O-GlcNAcylation decreased at 24 h after SeV
infection (Figure 1A). Therefore, we examined the expression ofFrontiers in Immunology | www.frontiersin.org 6immunoreactive OGT protein at various times after infection as
indicated. These observations revealed that the levels of OGT
protein decreased drastically in response to the strong induction
of the innate immune response (Figures 2A, B, S2A). To
investigate this observation further, OGT mRNA levels were
measured by real-time RT-PCR. Surprisingly, we found that
transcription of OGT decreased dramatically at all time points
examined, most notably at the earliest time point after infection
(i.e., 4 h) (Figures 2C, S2B). Given that some viruses alter the
host transcriptome to facilitate their own replication and
proliferation, these results raised additional questions as to
whether the decrease in OGT transcription was driven directly
by the virus. To address this question, we transfected cells with
poly(I:C), which is a ligand capable of activating RLR-mediated
signaling in the absence of an overt virus infection. Similar to
SeV infection, transfection with poly(I:C) also promoted aA B
C
D E G H
IF
FIGURE 2 | Downregulated transcription of O-GlcNAc Transferase (OGT) in response to virus infection. (A) Immunoreactive OGT was evaluated via Western blot
analysis in HEK293 cells infected with SeV (100 HAU) at the time points indicated. (B) Expression of OGT and O-GlcNAc as shown in (A) was normalized to actin or
GAPDH. (C) Real-time qPCR was performed to measure OGT mRNA expression levels. (D) 10 mM Poly (I:C) was transfected into HEK293 cells which were
evaluated at the times indicated. Western blot analysis was performed to detect immunoreactive OGT protein. (E) OGT and O-GlcNAc as shown in (D) were
normalized to levels of actin or GAPDH. (F) Real-time qPCR was performed to measure OGT mRNA expression levels. (G) To activate RLR signaling, the N-RIG-I
plasmid was used to transfect HEK293 cells; cells were collected at the times indicated to measure OGT protein and mRNA expression levels. (H) Expression levels
of OGT and O-GlcNAc in (G) were normalized to actin or GAPDH. All experiments were repeated at least three times. (I) Real-time qPCR was performed to measure
OGT mRNA expression levels. Each figure was statistically analyzed with the indicated n number. (A), (B) n = 4, (D, E, G, H) n = 3 and (C, F, I) n = 3. Data are
presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001.February 2021 | Volume 11 | Article 589259
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addition, in MEF primary cells and HDF (Human dermal
fibroblast) primary cells, OGT protein levels decreased in
response to poly(I:C) transfection (Figure S2D). Furthermore,
levels of OGT mRNA were also significantly reduced in cells
transfected with poly(I:C) (Figures 2F, S2E). As such, we
inferred that the host response, rather than the virus per se,
promoted the observed reductions in OGT gene transcription.
This conclusion was supported by findings associated with the
overexpression of activated (N-)RIG-I. Overexpression of N-
RIG-I has been reported to promote MAVS activation (24); N-
RIG-I DNA constructs were transfected into HEK293 cells,
resulting in a decrease in OGT protein and mRNA levels; these
findings are consistent with the results shown in Figures 2D, F
(Figures 2G, I).
O-GlcNAcylation Directly Regulates
Mitochondrial Antiviral Signaling Protein-
Mediated Expression of Interferon-b
Given the decline in O-GlcNAcylation in various cell types and the
resulting impact on RLR-mediated signaling and the downstream
production of IFN-b, we then aimed to identify the specific
mechanisms underlying this response. MAVS is a powerful
immune sensor that promotes innate immune responses and
stimulates the production of IFN-b (25, 26). We overexpressed
MAVS in HEK293 cells to induce a condition that mimicked viral
infection (5). Interestingly, the IFN-bmRNA expression induced in
response to MAVS overexpression dropped significantly in cells
treated with Thiamet-G (Figure 3A). Furthermore, the expression
of IFN-b mRNA was inhibited when MAVS and OGT were both
overexpressed. By contrast, expression of IFN-bmRNA induced by
overexpression of MAVS overexpression increased even further
when cellular O-GlcNAcylation was reduced by co-overexpression
of OGA (Figure 3B). The same findings were observed in assays
designed to detect IFN-b protein synthesis and secretion (Figure
3C). On the basis of these results, we hypothesized that cellular O-
GlcNAcylation may have a direct role in the regulation of MAVS
activity, notably upon activation of RLR signaling. To examine this
hypothesis, MAVS knock-down was achieved using targeted
siRNAs (Figure S3A). As shown in Figure 3D, Thiamet-G
treatment inhibited the expression of IFN-b in response to SeV
infection in the control group but in cells transfected with siMAVS.
As such, we concluded that O-GlcNAcylation regulates RLR
signaling in a MAVS-dependent manner.
Mitochondrial Antiviral Signaling Protein Is
a Direct Target of O-GlcNAc Transferase
O-GlcNAc transferase (OGT) catalyzes the O-GlcNAcylation of
numerous mitochondrial proteins (12). As such, we evaluated O-
GlcNacylation of endogenously expressed MAVS via precipitation
studies conducted with succinylated-wheat germ agglutinin
(sWGA). Using this approach, we found that endogenous MAVS
was O-GlcNAcylated (Figure 3E). Furthermore, recombinant
(overexpressed) MAVS was also O-GlcNAcylated; O-
GlcNAcylation of this target was increased in response to OGT
overexpression (Figures 3E, S3B). We also evaluated O-Frontiers in Immunology | www.frontiersin.org 7GlcNAcylation of other intracellular proteins including STING,
which is another immune sensor, as well as IKKϵ, a TBK1-
associated factor involved in the innate immune response. Despite
these efforts, our results indicated that MAVS alone was targeted for
O-GlcNAcylation (Figure 3F). Even when IKKϵ or TBK1 was
overexpressed with Flag tagged MAVS to activate MAVS
signaling, we could not detect O-GlcNAcylation of IKKϵ or TBK1
(Figure S3C). We divided the 540-amino acid sequence of MAVS
into N-terminal (1–265) and C-terminal (266–540) fragments to
identify specific sites of O-GlcNAcylation. Full-length MAVS, the
MAVS N-terminal fragment, and the MAVS C-terminal fragment
were all overexpressed in HEK293 cells; O-GlcNAcylation of each
polypeptide was investigated by sWGA-mediated precipitation.
Significantly, we detected O-GlcNAcylation of both N- and C-
terminal fragments of MAVS (Figure 3G). These results clearly
indicate that there are potential O-GlcNAcylation sites in the N-
terminal region of MAVS besides that previously identified (i.e.,
Serine 366) in its C-terminal region (9).
Mitochondrial Antiviral Signaling Protein
Contains a Heavily O-GlcNAcylated
Serine-Rich Region That Can Inhibit
RIG-I-Like Receptors-Mediated Signaling
O-GlcNAcylation takes place at hydroxyl groups found on serine
and threonine residues. Notably, serine and threonine represent
20% of the amino acids (108 of the total 540) in the MAVS
polypeptide. O-GlcNAcylation sites within MAVS were
identified by fusion mass spectrometry (Fusion M/S). A total
of 20 O-GlcNAcylation sites were identified by this method
(Figures 4A–C, S4AF). Remarkably, seven O-GlcNAcylation
sites that were adjacent to one another were identified in a
serine-rich region within the aforementioned N-terminal
fragment of MAVS (Figure 4C). To evaluate the function of
these O-GlcNAc modifications, we generated a MAVS mutant
that deleted nine amino acids, including the seven potential O-
GlcNAcylation sites (D249–257); O-GlcNAcylation levels were
explored in HEK293 cells that overexpressed both the wild-type
and the MAVS D249–257 deletion mutant. Consistent with the
fusion M/S results, the O-GlcNAcylation levels of the MAVS
D249–257 mutant were significantly lower than those detected in
the MAVS wild-type polypeptide (Figure 4D). O-GlcNAcylation
levels were also dramatically reduced in the 7S/T!7A
substitution mutant in which all seven O-GlcNAcylation sites
were substituted with alanine (Figure 4E). As such, we
hypothesized that O-GlcNAcylation at the serine-rich region of
MAVS would have an impact on IFN-b production in response
to SeV infection. First, we examined phosphorylation of IRF3 to
determine whether reduced O-GlcNAcylation in the MAVS
D249–257 mutant had an impact on RLR-mediated signaling.
We found that phosphorylation of IRF3 was increased in
HEK293 cells transfected with MAVS D249–257 over that
observed in response to MAVS wild-type when cells were
infected with SeV (Figure 4F). Consistent with the results
observed in HEK293 cells transfected with the MAVS D249–
257 mutant, phosphorylation of IRF3 was further enhanced in
cells transfected with the 7S/T!7A substitution mutant inFebruary 2021 | Volume 11 | Article 589259
Seo et al. O-GlcNAcylation of MAVS Inhibits Its ActivityA B
E F G
C D
FIGURE 3 | O-GlcNAcylation directly regulates MAVS-mediated expression of IFN-b. (A) IFN-b mRNA was measured by real-time qPCR was conducted to measure
mRNA expression levels under conditions that mimicked viral infections in HEK293 cells by treating with 1 mM Thiamet-G for 24 h before induction of MAVS
overexpression via transfection of a Flag-MAVS expression plasmid. (B) IFN-b mRNA expression induced by MAVS overexpression under conditions mimicking virus
infection was measured by real-time qPCR together with co-overexpression of OGT and OGA. (C) An ELISA assay was conducted to compare secretion of IFN-b in
response to OGT overexpression with that observed in response to MAVS overexpression (control condition). (D) Knock-down of MAVS in HEK293 cells was
performed via transfection with MAVS-targeting siRNAs and examined after 48 h. Inhibition of SeV-induced IFN-b production in response to treatment with Thiamet-
G was not observed in cells with MAVS knock-down. n.s indicated not statistically significant. (E) Precipitation using the lectin, sWGA, was conducted to
demonstrate O-GlcNAcylation of endogenous MAVS and to examine the increase in MAVS O-GlcNAcylation in response to OGT overexpression. 1.5—2 mg of
whole cell lysates (WCLs) obtained from HEK293 were incubated with agarose-conjugated sWGA overnight at 4oC. Purified proteins in sWGA precipitates were
eluted with 2× SDS loading buffer then analyzed via Western blotting. (F) IP and Western blots were performed to identify O-GlcNAcylated proteins associated with
RLR signaling. 1.5—2 mg of WCLs obtained from HEK293 were incubated with agarose-conjugated anti-Myc antibodies for 2 h at 4°C. Purified proteins in IP
precipitates were eluted with 2× SDS loading buffer and then analyzed via Western blotting. Of the major molecules involved in RLR signaling, only MAVS was
subject to O-GlcNAc modification. H.C means heavy chain. (G) Precipitation with sWGA was to confirm the O-GlcNAcylation of the N- or C-termini of MAVS.
Plasmids promoting overexpression of MAVS 1-265 and 266-540 were transfected and evaluated after 24 h with or without OGT. 1.5 to 2 mg of WCLs obtained
from HEK293 were incubated with agarose-conjugated sWGA overnight at 4°C. Purified proteins in SWGA precipitates were eluted with 2× SDS loading buffer then
analyzed via Western blotting. The 1–265 and 266–540 regions are both modified with O-GlcNAc. All experiments were repeated at least three times. (A–G) –
indicated cells transfected with flag or myc empty vectors. Each figure was statistically analyzed with the indicated n number. (A) n = 6, (B) n = 5, (C) n = 3, (D) n=3.
Statistical significance was determined by two tailed student t-test. Data are presented as mean ± SEM; *p < 0.05, **p < 0.01.Frontiers in Immunology | www.frontiersin.org February 2021 | Volume 11 | Article 5892598





FIGURE 4 | MAVS contains a heavily O-GlcNAcylated serine-rich region that inhibits RLR signaling. (A) Fusion M/S analysis was conducted to identify sites of O-
GlcNAcylation in MAVS. EThcD spectra of the O-glylcopeptide LPGPTGSVVSTGTSFSSSSPGLASAGAAEGK from human MAVS is as shown. The site of O-GlcNAc
modification was identified as serine 249. The y, b, C, and z fragments detected are as indicated in the sequence. (B, C) MAVS O-GlcNAcylation sites and the
protein structures of the wild-type and MAVS D249–257 mutant. (D, E) IP and Western blots were performed to compare the O-GlcNAcylation of wild-type MAVS
with (D) the mutant in which the serine-rich region including the O-GlcNAcylation sites were detected and (E) the mutant with the 7S/T to alanine substitution. The
pRK5-flag-tagged MAVS wild-type and mutant plasmids were transfected into HEK293 cells and evaluated 24 h later. WCLs were incubated with agarose-
conjugated anti-FLAG antibody (M2) for 1–2 h at 4°C. (F, G) Western blot analysis of phospho-IRF3 (p-IRF3) in WCLs from HEK293 cells. The p-IRF3 levels were
determined by transfection with pRK5-flag-tagged MAVS wild-type, (F) deletion mutant, or (G) substitution mutant plasmids followed by evaluation 24 h later; cells
were infected with SeV (100 HAU) for 24 h followed by Western blotting. (H) Expression of IFN-b mRNA induced by overexpression of wild-type and mutant MAVS
was measured by real-time qPCR. The decreased levels of IFN-b expression in response to the S366A mutant underwent full recovery in response to the D249–257
mutant containing S366A when compared to the wild type. n = 3. (D–H) Experiments were performed at least three times. (D–H) – indicated cells transfected with
flag or myc empty vectors. Statistical significance of (H) was determined by one-way ANOVA. Results were presented as mean ± SEM; *p < 0.05, **p < 0.01.Frontiers in Immunology | www.frontiersin.org February 2021 | Volume 11 | Article 5892599
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of IFN-b mRNA was also significantly elevated in cells
transfected with the MAVS D249–257 mutant compared to the
wild type (Figure 4H). Finally, and consistent with previous
reports that describe O-GlcNAcylation at MAVS Serine 366 and
its role in promoting RLR-mediated signaling, decreased
expression of IFN-b was observed in cells transfected with a
MAVS S366A mutant. Surprisingly, when compared to the
results obtained from cells transfected with the MAVS S366A
mutant, we observed full recovery of IFN-b expression upon
deletion of the serine-rich 249–257 region from the S366A
mutant. Collect ively , these results suggest that O-
GlcNAcylation at the serine-rich region of MAVS (amino acids
249–257) modulates MAVS-activated RLR-mediated signaling
via a mechanism that is distinct and different from that
associated with O-GlcNAcylation of S366.
Mitochondrial Antiviral Signaling Protein
O-GlcNAcylation Interferes With the
Formation of Its Aggregates
Thus far, we have demonstrated O-GlcNAcylation of the MAVS
249–257 serine-rich region results in down-regulated RLR signaling
infection with SeV. We further examined the mechanism by which
O-GlcNAcylation at this site suppresses the IFN-b response. Full
activation of MAVS requires self-aggregation at the mitochondrial
outer membrane. The aggregation and resolution responses of
MAVS are strongly regulated by post-translational modifications,
including ubiquitination (21, 27, 28). Results from earlier studies
indicated that O-GlcNAcylation inhibited the formation of prion-
like aggregates of proteins that include a-synuclein and tau (29, 30);
as such, its role in preventing the formation of critical MAVS
aggregates was explored. Intriguingly, upon co-overexpression of
both MAVS and OGA, MAVS could form aggregates as revealed in
a semi-denaturing detergent-polyacrylamide gel electrophoresis
(SDD-PAGE) assay (Figure 5A). Furthermore, the degree of
MAVS aggregation increased drastically in response to OGT
knock-down (Figures 5B, S5A). Consistent with these results,
endogenously generated MAVS aggregates were detected at
higher levels in cells subjected to OGT knock-down during the
later stages of SeV infection (at 16 h; Figure 5C). To exclude the
possibility that the observed increase in MAVS aggregation was due
to changes in MAVS protein stability that might result from
reduced levels of O-GlcNAcylation, MAVS protein levels were
evaluated in HEK293 and A549 cells treated with cycloheximide.
Under these conditions, MAVS stability was not diminished in
the presence or absence of Thiamet-G (Figures S5B, S5C).
O-GlcNAcylation of endogenously expressed MAVS was found to
have decreased at 24 h after SeV infection (Figures 5D, S5D).
GlcNAc competition studies revealed thatO-GlcNAcylation MAVS
was significantly reduced under these conditions (Figure 5D).
We then examined the degree of MAVS aggregation in cells
overexpressing the MAVS D249–257 deletion mutant. As
expected, the degree of aggregation was higher in cells
overexpressing the MAVS D249–257 deletion mutant than that
observed in cells overexpressing the MAVS wild type (Figure 5E);
interestingly, we observed no increase in the degree of aggregationFrontiers in Immunology | www.frontiersin.org 10when comparing responses of the MAVS wild-type protein to that
of the S366A mutant. Nevertheless, we were still able to observe the
increased degree of aggregation in the deletion of the serine-rich
249–257 from the S366A mutant compared to the S366A mutant
(Figure 5E). These results suggest that O-GlcNAcylation of MAVS
specifically at the serine-rich region (249–257), restricts the
formation of MAVS aggregates.
Mitochondrial Antiviral Signaling Protein
O-GlcNAcylation Interferes With Its
Interaction With TRAF3
The sequence of MAVS contains several TRAF-interacting motifs
(TIMs) that facilitate its interactions with these signaling molecules.
The interaction between MAVS and TRAFs is critical to activate
MAVS-mediated downstream signaling. TRAF3 is recruited to
aggregates of MAVS and thereby promotes the activation of IRF3
via the K63-ubiquitination ofMAVS. The interaction betweenMAVS
and TRAF3 was examined through co-immunoprecipitation (co-IP)
studies designed to identify the mechanism by which O-
GlcNAcylation of MAVS inhibits expression of IFN-b. The
interaction between MAVS and TRAF3 was inhibited in cells
overexpressing OGT (Figure 5F). Furthermore, we found that the
interaction between TRAF3 and MAVS D249–257 was significantly
enhanced compared with its interaction with wild-type MAVS
(Figure 5G). Since there are previous reports that O-GlcNAcylation
of MAVS regulates ubiquitination of MAVS, we needed to confirm
whether O-GlcNAcylation at the serine-rich region (amino acids
249–257) also regulates ubiquitination of MAVS (9, 10). We
confirmed that MAVS ubiquitination was slightly increased in
MAVS D249–257 deletion mutant compared to wild type (Figure
S5E). As such, we concluded that O-GlcNAcylation at the serine-rich
region ofMAVS specifically inhibits RLR signaling by interfering with
the interaction between MAVS and TRAF3. Taken together, these
findings suggest thatO-GlcNAcylation is involved inmodulating host
defense mechanisms.DISCUSSION
Dysregulated energy metabolism is directly linked to the
pathogenesis of numerous diseases; an imbalance in energy
metabolism has also been found to disrupt the host defense
system (31, 32). In recent years, attempts have been made to
identify a role for glucose metabolism, the central pathway
associated with energy metabolism, in modulating one or more
aspects of the innate immune response. As but one example,
several groups have examined the relationship between glucose
metabolism and RLR-mediated signaling. Among these findings,
RLR-induced production of type-I IFNs was observed under
conditions in which glucose metabolism was inhibited and that
cells maintained in a low-glucose environment could produce
higher levels of IFN than cells maintained in a high-glucose
medium (22). By contrast, results from another study revealed
that activation of RLR-mediated signaling resulted in an increase
in glucose metabolism (9). These conflicting results will most
certainly be important toward the effort to understand the fullFebruary 2021 | Volume 11 | Article 589259
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FIGURE 5 | O-GlcNAcylation of MAVS interferes with aggregate formation and interactions with TRAF3. (A) Non-reducing SDD-PAGE analysis was conducted to
determine the level of MAVS aggregation. MAVS overexpression in HEK293 cells induced aggregate formation levels with or without overexpression of OGA.
(B) Knock-down of OGT in HEK293 cells was detected at 48 h after transfection with specific siRNAs; this was performed before induction of MAVS overexpression
for 24 h, after which SDD-AGE analysis was performed. (C) Endogenous MAVS aggregates were detected by SDD-AGE under conditions of OGT knock-down.
HEK293 cells were transfected with siOGT; 48 h later, cells were infected with SeV (100 HAU) and evaluated at 16 h after infection. MAVS aggregates were
normalized to the expression level of endogenous MAVS. (D) Precipitation was performed with sWGA followed by Western blot analysis to detect the O-
GlcNAcylation levels of MAVS after a longer period of time after SeV infection (100 HAU). Cells were infected with SeV for 24 h before collection. WCLs were
incubated with sWGA-conjugated beads overnight at 4°C and then were eluted for Western blot analysis. (E) An SDD-AGE assay was conducted to compare the
levels of aggregation of wild-type MAVS and mutants with deleted O-GlcNAcylation sites. The pRK5-flag-tagged MAVS wild-type and mutant (D249–257, S366A,
D249–257 containing S366A) plasmids were used to transfect HEK293 cells and were evaluated after 24 to 48 h. (F) A co-IP assay was performed to evaluate the
interactions between MAVS and TRAF3. The pRK5-flag-tagged MAVS and HA-TRAF3 expression plasmids co-overexpressed in HEK293 cells both with and without
Myc-OGT overexpression. (G) A co-IP assay was performed to evaluate the interactions between wild-type or the D249–257 mutant MAVS and HA-TRAF3 in
HEK293 cells. Expression plasmids were used to transfect cells that were evaluated at 24 to 48 h. All experiments were repeated at least three times.
(A–G) – means cells transfected with flag or Myc or HA empty vectors.Frontiers in Immunology | www.frontiersin.org February 2021 | Volume 11 | Article 58925911
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glucose metabolism. In this study, we have demonstrated that
levels of O-GlcNAcylation, which are known to respond rapidly
to extracellular stimuli (33), decrease significantly in response to
infection with an RNA virus; this ultimately leads to innate
immune responses in target epithelial cells at later time points
during infection that are associated with production of IFN-b.
The functional mechanisms underlying cel lular O-
GlcNAcylation and their role in promoting RLR-mediated
signaling are as shown in Figure 6. The host cell responds to
virus infection by shutting down the expression of OGT. This
response results in decreased levels of OGT and thus global
depletion of cellular O-GlcNAcylation. This response has a
specific impact on O-GlcNAcylation at the serine-rich region
(amino acids 249–257) of MAVS; this promotes MAVS
aggregation and enhances the interactions between MAVS and
TRAF3. Because of these interactions, IRF3 is phosphorylated,
undergoes dimerization, and is translocated into the nucleus
where it promotes IFN-b transcription and thus activates IFN-b-
mediated host defense responses. Taken together, the results
presented in this study reveal that O-GlcNAcylation is a key link
between glucose metabolism and the innate immune response.
Our study elucidated an important role for O-GlcNAcylation
of MAVS; this post-translational modification resulted in
suppression of RLR-mediated signaling in epithelial cells via a
mechanism that was clearly different and distinct from those
previously reported for MAVS Ser366 or for the seven associated
sites at amino acids 322–347 within the MAVS polypeptide (9,
10). In these previous studies, O-GlcNAcylation of MAVS
resulted in increased IFN-b production at relatively early time
points after viral, similar to those identified for the IFN-b
response of macrophages. However, in the case of epithelial
cells, the time IFN-b production is typically observed at laterFrontiers in Immunology | www.frontiersin.org 12time points when compared with those observed in infected
macrophages (Figure 1B). We identified an unexpected
decreased in the transcription of OGT in response to virus
infection; this resulted in the global reduction of cellular
O-GlcNAcylation and the specific reduction of the
O-GlcNAcylation of MAVS. Our study revealed a mode of
action that explains how O-GlcNAc modification modulates
protein function in a site-specific manner. Furthermore, this
mechanism suggests that O-GlcNAcylation, similar to
phosphorylation, may serve as a central communicator
promoting immune-mediated signal transduction.
The results of our study revealed drastic reductions in mRNA
encoding OGT at early time points following SeV infection
(Figure 2). This decline in OGT mRNA was not a response to
specific viral proteins but appears to be modulated by host
defense mechanisms. As such, we determined that the host
response itself regulates transcription of OGT. Therefore, we
proceeded to determine how the observed reduction of OGT
mRNA was ultimately linked to the activation of RLR-mediated
signaling. Given the recent reports indicating that OGT mRNA
stability could be modulated by specific miRNAs (34, 35), we
inferred that alterations of OGT might relate to specific post-
transcriptional alterations that could promote mRNA decay.
Further investigation will be needed to determine a role for
virus-mediated activation of negative TFs and transcriptional co-
repressors of OGT.
Some viruses are capable of sequential expression of
immediate early (IE), early, and late viral genes that serve to
support of their replication and propagation (36). O-
GlcNAcylation of host transcriptional factors that promote
viral gene expression, including HCF-1 and Sp1, have also
been reported (37–39). However, we are not aware of any
reports that describe host-mediated regulation of OGTFIGURE 6 | Schematic of the proposed model depicting O-GlcNAcylation of MAVS at S249-S257 and its role in RLR-mediated signaling. The functional mechanism
underlying cellular O-GlcNAcylation of MAVS and its role in promoting RLR-mediated signaling is described in Figure 6.February 2021 | Volume 11 | Article 589259
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our knowledge, this is the first demonstration of transcriptional
modulation of OGT mediated by virus-infected host cells that
resulted in the reduction of O-GlcNAcylation and concomitant
induction of an innate immune response. Moreover, it is
important to discuss the role of O-GlcNAcylation of host TFs.
For example, HCF1 is a host TF required for the transcriptional
transactivation of the IE genes of HSV. O-GlcNAcylation of
HCF1 promotes increased expression of HSV genes. When OGT
activity is chemically inhibited by the OGT inhibitor, OSMI-1,
late capsid formation of HSV and replication of both HSV and
cytomegalovirus are inhibited (18). Furthermore, several of the
TFs involved in the regulation of human immunodeficiency virus
(HIV)-1 genes are modified by O-GlcNAcylation, including AP-
1, yin-yang1 (YY1), NFATc1, NF-kB, and Sp1 (40–42). Among
these findings, O-GlcNAcylation of Sp1 suppresses the long
terminal repeat (LTR) region of HIV-1 and thereby inhibits
HIV-1 replication (39). Besides the viral life cycle regulation via
O-GlcNAcylation of host TFs, we have demonstrated that the
virus infection results in alterations to the transcriptional
patterns of the gene encoding the host OGT; we have shown
that this is a host antiviral defense mechanism that ultimately
leads to the continuous production of IFN-b.
In this study, we examined the functional significance of O-
GlcNAcylation of the MAVS serine-rich region (249–257).
However, the MAVS D249–257 deletion mutant still showed
weak O-GlcNAcylation by OGT; this result suggested that there
are likely to be additional O-GlcNAcylation sites on MAVS.
Twenty potential MAVS O-GlcNAcylation sites were identified
by Fusion M/S, including O-GlcNAcylation at Ser366 and a
region including amino acids 324–347 on MAVS; these findings
are consistent with those recently reported by Li et al (2018). and
Song et al (2019).. The function of O-GlcNAcylation of Ser366
and the amino acids 324–347 region may be to promote RLR-
mediate signaling in macrophages. However, we found that the
aggregation and activity of MAVS were increased in epithelial
cells with diminished levels of OGT and O-GlcNAcylation.
Therefore, a more systematic approach will be needed to
examine the nature of these differences and to identify their
unique and important roles in promoting immune
cell activation.
Additionally, our findings also confirmed that the viability of
HEK293 and A549 cells was not significantly decreased within
the 24 h after virus infection in as determined by MTT assays
(Figure S5F). Ultimately, the absence of virus clearance
mechanisms led to the death of host cells in response to the
long-term infection. O-GlcNAcylation has protective effects
concerning cell death; specifically, mechanisms that promote
cell death also reduces the cellular levels of O-GlcNAcylation.
However, cells that have been infected for a long period of time
cannot activate IRF3 phosphorylation or produce IFN-b despite
reductions in O-GlcNAcylation. As such, our study did present
any reductions in O-GlcNAcylation associated with cell death
and/or its impact on innate immune response.
MAVS activity is clearly regulated by the degree of O-
GlcNAcylation as well as by processes including ubiquitinationFrontiers in Immunology | www.frontiersin.org 13and phosphorylation (9, 21, 43–45). Furthermore, there is a yin–
yang relationship betweenO-GlcNAcylation and phosphorylation.
Interestingly, we also identified a phosphorylation site in MAVS
(Serine 258). This phosphorylation site is very close to one of the
O-GlcNAcylation sites identified in this study; as such, future
studies will determine whether there are cooperative or
competitive interactions between phosphorylation and O-
GlcNAcylation at these sites. The results of this type of
investigation will provide insight into how O-GlcNAcylation
communicates with phosphorylation to modulate host
defense mechanisms.
In summary, we demonstrated that MAVS-mediated RLR
signaling, which is necessary for antiviral immune responses of
epithelial cells, is inhibited by O-GlcNAcylation of MAVS, which
restricts the formation of self-aggregates. O-GlcNAcylation of
MAVS is also impaired via reduction of OGT mRNA expression,
which is a newly discovered host defense mechanism that serve
to accelerates innate immune responses. An improved
understanding of O-GlcNAcylation and its role in RLR-
mediated signaling in RNA virus-infected cells may present
OGT as a potential therapeutic target for the treatment of
patients with immune dysfunction.DATA AVAILABILITY STATEMENT
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